Table 1.
Study design in all included RCTs.
Study | Country | Surgery | Pts. No. RIPC vs Ctrl | RIC protocol | RIC initiation to CPB | Placebo Control | Renal Endpoints | Baseline Creatinine level (mg/dl) | AKI Definition | F-up | Jadad score | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cycles × I/R | Cuff pressure | |||||||||||
Rahman17 | UK | CABG (On) | 42 vs 38 | 3 × 5 min/5 min at upper limb | 200 mmHg | 74 mins | Yes | AKI, RRT, Mortality | 1.10 | SCr↑ >0.5 mg/dl | 30 d | 5 |
Thielmann28 | German | CABG (On) | 27 vs 26 | 3 × 5 min/5 min at upper limb | ||||||||
Venugopal19 | UK | Combined | 38 vs 40 | 3 × 5 min/5 min at upper limb | 200 mmHg | <45~60 mins | Yes | AKI, RRT, Mortality | 0.95 | AKIN | 30 d | 4 |
Zimmerman18 | USA | Combined | 59 vs 59 | 3 × 5 min/5 min at thigh | 200 mmHg | N.A | No | AKI, RRT, Mortality | 0.94 | AKIN | In-hospital | 5 |
Choi20 | Korea | Valve | 38 vs 38 | 3 × 10 min/10 min at thigh | 250 mmHg | >70 mins | Yes | AKI, RRT | 0.915 | AKIN | In-hospital | 5 |
Lomivorotov29 | Russian | CABG (On) | 40 vs 40 | 3 × 5 min/5 min at upper limb | 200 mmHg | 30~50 mins | Yes | RRT | N.A | RRT | In-hospital | 1 |
Lucchinetti30 | Canada | CABG (On) | 27 vs 28 | 4 × 5 min/5 min at thigh | 300 mmHg | N.A | Yes | RRT | 1.01 | RRT | 6 mon | 5 |
Hong31 | Korea | CABG (Off) | 35 va 35 | 4 × 5 min/5 min at thigh | 200 mmHg | 18 mins | Yes | RRT, Mortality | 1.10 | RRT | 30 d | 3 |
Kim21 | Korea | Valve | 27 vs 27 | 3 × 10 min/10 min at thigh | 250 mmHg | Pre- plus Post-CPB | Yes | AKI, RRT, Mortality | N.A | AKIN | In-hospital | 5 |
Young32 | New Zealand | Combined | 48 vs 48 | 3 × 5 min/5 min at upper limb | 200 mmHg | N.A | Yes | AKI, RRT, Mortality | 1.10 | RIFLE | 30 d | 5 |
Gallagher22 | UK | CABG | 43 vs 43 | 3 × 5 min/5 min at upper limb | 50 mmHg > SBP | N.A | Yes | AKI, RRT, Mortality | 1.37 | AKIN | 30 d | 2 |
Candilio23 | UK | Combined | 57 vs 54 | 2 × 5 min/5 min at upper limb and thigh | 200 mmHg | <45 mins | Yes | AKI, RRT | N.A | AKIN | In-hospital | 5 |
Hong33 | Korea | Combined | 644 vs 636 | 4 × 5 min/5 min at thigh | 200 mmHg | N.A | Yes | AKI | N.A | AKIN | In-hospital | 5 |
Hu34 | China | Valve | 101 vs 100 | 4 × 5 min/5 min at thigh | 600 mmHg | Post-CPB | Yes | AKI, Mortality | 0.83 | AKIN | In-hospital | 4 |
Pinaud35 | France | Valve | 50 vs 49 | 3 × 5 min/5 min at upper limb | 200 mmHg | 91 mins | Yes | AKI, RRT | N.A | AKIN | In-hospital | 3 |
Hausenloy25 | UK | Combined | 749 vs 772 | 4 × 5 min/5 min at upper limb | 200 mmHg | 105 min | Yes | AKI, RRT, Mortality | N.A | KDIGO | In-hospital | 5 |
Zarbock26 | German | Combined | 120 vs 120 | 3 × 5 min/5 min at upper limb | 200 mmHg or 50 mmHg > SBP | N.A | Yes | AKI, RRT, Mortality | 1.15 | KDIGO | In-hospital | 5 |
Meybohm24 | German | Combined | 692 vs 693 | 4 × 5 min/5 min at upper limb | ≥200 mmHg or 15 mmHg > SBP | N.A | Yes | RRT, Mortality | N.A | RIFLE | In-hospital | 5 |
Cao37 | China | Valve | 30 vs 30 | 3 × 5 min/5 min at lower limb | 200 mmHg | N.A | Yes | RRT | N.A | RRT | In-hospital | 3 |
Walsh36 | Canada/US/India/China | Combined | 128 vs 130 | 3 × 5 min/5 min at thing | 300 mmHg | N.A | Yes | AKI, RRT, Mortality | 1.07 | AKIN | 6 mon | 5 |
Kim27 | Korea | Combined | 80 vs 80 | 4 × 5 min/5 min at upper limb | 200 mmHg | 29.4 h | Yes | AKI, RRT, Mortality | 0.9 | AKIN | In-hospital | 5 |
Note: RCT, randomized controlled trials; CABG, coronary artery bypass graft; I/R, ischemia/reperfusion; SBP, systolic blood pressure; atm, atmosphere; AKI, acute kidney injury; RRT, renal replacement treatment; SCr, serum creatinine; eGFR, estimated glomerular filtration rate; N.A, not available; AKIN, Acute Kidney Injury Network; RIFLE, Risk, Injury, Failure, Loss of renal function and End-stage renal disease; KDIGO, Kidney Disease: Improving Global Outcomes; RIPC, remote ischemic preconditioning; Ctrl, control.